Search Results - "Sollie, F"

  • Showing 1 - 16 results of 16
Refine Results
  1. 1

    Dose‐finding and efficacy study for i.m. artemotil (beta‐arteether) and comparison with i.m. artemether in acute uncomplicated P. falciparum malaria by Looareesuwan, S., Oosterhuis, B., Schilizzi, B. M., Sollie, F. A. E., Wilairatana, P., Krudsood, S., Lugt, Ch. B., Peeters, P. A. M., Peggins, J. O.

    Published in British journal of clinical pharmacology (01-05-2002)
    “…Aims  The antimalarial efficacy/pharmacodynamics and pharmacokinetics of intramuscular (i.m.) artemotil in Thai patients with acute uncomplicated falciparum…”
    Get full text
    Journal Article Conference Proceeding
  2. 2

    Pharmacokinetic profile of a modified release formulation of trimetazidine (TMZ MR 35 mg) in the elderly and patients with renal failure by Barré, J., Ledudal, P., Oosterhuis, B., Brakenhoff, J.P.G., Wilkens, G., Sollie, F.A.E., Tran, D.

    Published in Biopharmaceutics & drug disposition (01-05-2003)
    “…Objectives – To study the effect of age and renal function on the pharmacokinetic profile of a modified release tablet of trimetazidine (TMZ MR 35 mg)…”
    Get full text
    Journal Article
  3. 3

    Safety, tolerability and pharmacokinetics of oral S-3304, a novel matrix metalloproteinase inhibitor, in single and multiple dose escalation studies in healthy volunteers by van Marle, S, van Vliet, A, Sollie, F, Kambayashi, Y, Yamada-Sawada, T

    “…A novel sulfonamide derivative, S-3304, was discovered as a potent matrix metalloproteinase (MMP) inhibitor. It is a more specific inhibitor to MMP-2 and MMP-9…”
    Get full text
    Journal Article
  4. 4

    Single-dose subcutaneous administration of recombinant human parathyroid hormone [rhPTH(1-84)] in healthy postmenopausal volunteers by Schwieter, Hendrik Reinier, Groen, Edwin W. J., Sollie, Frans A. E., Jonkman, Jan H. G.

    Published in Clinical pharmacology and therapeutics (01-03-1997)
    “…Background Parathyroid hormone [PTH(1–84)] is intended for treatment of osteoporosis because it stimulates new bone formation of normal structure and…”
    Get full text
    Journal Article
  5. 5

    The absolute bioavailability and effect of food on the pharmacokinetics of zolmitriptan in healthy volunteers by Seaber, Emma J., Peck, Richard W., Smith, Deborah A., Allanson, John, Hefting, Nanco R., Van Lier, Jan J., Sollie, Frans A. E., Wemer, Johan, Jonkman, Jan H. G.

    Published in British journal of clinical pharmacology (01-11-1998)
    “…Aims Zolmitriptan (Zomig (formerly 311C90)) is a novel 5‐HT1B/1D receptor agonist developed for the acute oral treatment of migraine. A highly sensitive…”
    Get full text
    Journal Article
  6. 6

    Dose-dependent uricosuric effect of ambroxol by OOSTERHUIS, B, STORM, G, CORNELISSEN, P. J. G, SU, C. A. P. F, SOLLIE, F. A. E, JONKMAN, J. H. G

    Published in European journal of clinical pharmacology (01-03-1993)
    “…Ambroxol is known to promote bronchial secretion and is used as an expectorant. Previous studies had suggested that high doses of ambroxol could reduce the…”
    Get full text
    Journal Article
  7. 7

    Lack of pharmacokinetic interaction between vinpocetine and oxazepam by Storm, G, Oosterhuis, B, Sollie, FA, Visscher, HW, Sommer, W, Beitinger, H, Jonkman, JH

    Published in British journal of clinical pharmacology (01-08-1994)
    “…The influence of multiple doses of vinpocetine (10 mg three times daily) on the steady state plasma concentrations of oxazepam (10 mg three times daily) was…”
    Get full text
    Journal Article Conference Proceeding
  8. 8

    No pharmacokinetic or pharmacodynamic interaction between theophylline and the leukotriene biosynthesis inhibitor BAY x 1005 by Groen, H, Moesker, H L, Leeuwenkamp, O R, Sollie, F A, Jonkman, J H

    Published in Journal of clinical pharmacology (01-07-1996)
    “…An open, randomized, three-period crossover study was conducted to compare the steady-state pharmacokinetics, pharmacodynamics, and tolerability of concomitant…”
    Get more information
    Journal Article
  9. 9

    A pharmacokinetic and pharmacodynamic comparison of metoprolol CR/ZOK with a conventional slow release preparation by Oosterhuis, B, Jonkman, J, Zuiderwijk, P, Sollie, F

    Published in Journal of clinical pharmacology (01-02-1990)
    “…The plasma concentration-time profile and hemodynamic effects of metoprolol after the administration of metoprolol CR/ZOK, a multiple-unit controlled release…”
    Get more information
    Journal Article
  10. 10

    Absorption, Metabolism, and Excretion of Intravenously and Orally Administered [14C]Telmisartan in Healthy Volunteers by Stangier, Joachim, Schmid, Jochen, Türck, Dietrich, Switek, Heinz, Verhagen, Aalt, Peeters, Pierre A. M., van Marle, Sjoerd P., Tamminga, Wim J., Sollie, Frans A. E., Jonkman, Jan H. G.

    Published in Journal of clinical pharmacology (01-12-2000)
    “…The study was conducted in healthy male volunteers to evaluate the absorption, metabolic pattern, and mode of elimination of telmisartan, a nonpeptide…”
    Get full text
    Journal Article
  11. 11

    Pharmacokinetic modeling of the anticonvulsant response of oxazepam in rats using the pentylenetetrazol threshold concentration as pharmacodynamic measure by Dingemanse, J, Sollie, F A, Breimer, D D, Danhof, M

    “…This investigation developed strategies along which the anticonvulsant effect of oxazepam in the rat could be pharmacokinetically modeled. After determination…”
    Get more information
    Journal Article
  12. 12

    The Effect of Telmisartan on the Steady-State Pharmacokinetics of Digoxin in Healthy Male Volunteers by Stangier, Joachim, Su, Chung-An P. F., Hendriks, Maarten G. C., van Lier, Jan J., Sollie, Frans A. E., Oosterhuis, Berend, Jonkman, Jan H.G.

    Published in Journal of clinical pharmacology (01-12-2000)
    “…A multiple‐dose, open‐label, two‐period, crossover randomized study was conducted in 12 healthy male volunteers to investigate the effect of multiple‐dose…”
    Get full text
    Journal Article
  13. 13

    Steady-State Pharmacodynamics and Pharmacokinetics of Warfarin in the Presence and Absence of Telmisartan in Healthy Male Volunteers by Stangier, Joachim, Su, Chung-An P. F., Hendriks, Maarten G. C., van Lier, Jan J., Sollie, Frans A. E., Oosterhuis, Berend, Jonkman, Jan H. G.

    Published in Journal of clinical pharmacology (01-12-2000)
    “…The effects of multiple‐dose telmisartan on the steady‐state pharmacodynamics and pharmacokinetics of warfarin were assessed in 12 healthy young males in an…”
    Get full text
    Journal Article
  14. 14
  15. 15

    The influence of caffeine on the steady-state pharmacokinetics of theophylline by Jonkman, J H, Sollie, F A, Sauter, R, Steinijans, V W

    Published in Clinical pharmacology and therapeutics (01-03-1991)
    “…During this open, two-period crossover study in eight healthy volunteers, 1200 mg anhydrous theophylline was administered as a two-stage infusion during 24…”
    Get more information
    Journal Article
  16. 16